HSI1 28,371.26 0.00 128.75M
HSCEI1 10,770.31 0.00 2.59M
Back    Zoom +    Zoom - Block Traded
SIHUAN PHARM Drug Obtains NMPA Registration Approval
2019-06-19 17:04:47
SIHUAN PHARM (00460.HK) announced that the “non-PVC solid-liquid double chamber bag for cefuroxime sodium/sodium chloride injection” jointly developed by the Group and its associated company Beijing Ruiye Drugs Manufacture has been granted drug registration approval by the National Medical Products Administration (NMPA) of China. The specification of the Drug is 0.75g solid chamber, 100ml liquid chamber and 0.9g sodium chloride.

AAStocks Financial News
Web Site: www.aastocks.com